Skip to main content

Contact
Privacy Policy
Term of Use
Purchase Terms
COVID-19 Statement

Company
- About
- Leadership
- Contact
Careers
- Job Openings
Investors & Media

Select Page

Investors & Media

Investors & Media

Search query

Event Details

Investors & Media

KOL Webinar on Classical Homocystinuria and Pegtarviliase

10/27/2022 10:00 AM ET

PRESENTATION (opens in new window)

Investor Contact

investors@aeglea.com

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Aeglea BioTherapeutics Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Aeglea BioTherapeutics Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options *

News

Events & Presentations

Quarterly Reports

Annual Reports

SEC Filings

End of Day Stock Quote

Unsubscribe

Email Alert Sign Up Confirmation

Company

About
Leadership
Contact

Careers

Job
Openings

Investors & Media

Company Overview
Press Releases
Events & Presentations
Stock Information
Financials & Filings
Corporate Governance
Resources

© 2021 Aeglea BioTherapeutics. Privacy Policy Terms of Use Purchase Terms COVID-19 Statement

Powered By Q4 Inc. 5.120.1.3 (opens in new window)